Small molecule-mediated inhibition of the oxidoreductase ERO1A restrains aggressive breast cancer by impairing VEGF and PD-L1 in the tumor microenvironmentErsilia Varone, Ester Zito, Alessandro Cherubini et al.|Cell Death and Disease|2025Cited by 16